US - Genomics Market by Application, End-user, and Solution - Forecast and Analysis - 2023-2027

Published: Oct 2023 Pages: 145 SKU: IRTNTR76485

US - Genomics Market 2023-2027

The US- genomics market size is estimated to grow by USD 5,284.67 million at a CAGR of 10.45% between 2022 and 2027. 

Advances in genomics and the completion of the Human Genome Project (HGP) in 2003 have led to a significant reduction in the cost of sequencing. The reduced cost has increased the propensity of genomics R & Ds, which is positively impacting the growth of the US - genomics market. These technologies have been used in commercial applications such as clinical and research applications where rapid and large gene processing capabilities are needed, coupled with low-cost advantages, to encourage the adoption of gene sequencing analysis. Advanced genomics sequencing technologies such as NGS have led to a major reduction in the cost of performing sequential studies. By enabling a variety of sequence interactions, they also provide very robust detection and sensitivity. Reduction in cost has surged genetic research and commercial use of gene sequencing technologies for genomics characterization and analysis. 

Technavio has segmented the market into Application, End-user, Solution and Geography  

  • The application is classified into diagnostic, drug discovery, and others
  • The end-users are classified into hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others
  • The solution is classified into products and services

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the US Genomics Market During the Forecast Period?

To learn more about this report, Request Free Sample

US Genomics Market Segmentation by Application, End-user, and Solution

Application Analysis

Diagnostic

The market share growth by the diagnostic segment will be significant during the forecast period. The diagnostic segment of the US genomics market plays a crucial role in healthcare by using genomic information for disease direction, diagnosis, and treatment. The segments cover a number of techniques and technologies that allow an individual's genetic makeup to be analyzed in order to determine whether he or she has some sort of genetic disorder, assess disease risk, and guide personalized treatment decisions.

Get a glance at the market contribution of various segments View a PDF Sample

The diagnostic segment was valued at USD 2,369.94 million in 2017. Advancements in genomic technologies, such as next-generation sequencing and microarray-based testing, have revolutionized the field of diagnostics. These technologies make it possible to analyze huge quantities of DNA data rapidly and cheaply, which means a more precise diagnosis and tailored treatment plans. The growth of the segment is attributed to factors such as the increasing demand for gene therapy, personalized medicine, drug development, and the increasing incidence of cancer worldwide. 

End-user Analysis

Hospitals and clinics serve as the primary settings for genetic testing, analysis, and interpretation. Genomics is used by these facilities to diagnose diseases, develop individual treatment plans, assessment of disease diagnosis, development of personalized treatment plans, and health risk assessments in patients. To effectively leverage genomics, hospitals and clinics need to invest in infrastructure and expertise, including specialized laboratories, bioinformatics capabilities, and trained personnel. Thus, the increasing demand for personalized medicines, advancements in genomic technologies, improved cost-effectiveness of genomic testing, the rising prevalence of genetic disorders, and the growing awareness and acceptance of genomics in the medical community will drive the growth of the US genomics market size through the hospitals and clinics segment during the forecast period.

Buy Now Full Report and Discover More

Key US Genomics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Agilent Technologies Inc. - The company offers genomics solutions for applications such as cancer genomics, inherited disease, fragment analysis, and microarray solutions.

  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Caris Life Sciences
  • CENTOGENE NV
  • Color Health Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Invitae Corp.
  • LetsGetChecked
  • Myriad Genetics Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • Personalis Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

US Genomics Market Growth Analysis

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges. 

Significant US Genomics Market Trends

The increasing adoption of single-cell-based genomics analysis is a key trend in the US genomics market growth. The single-cell genomics analysis involves the extraction and isolation of genetic material at a single-cell level or from a homogenized cell sample. Single-cell genomics analysis is being used extensively in cancer research applications.

However, sequencing the DNA of an individual cell provides information on the genetic mutation that is carried by a small population of cells. This provides insight into variability in cell-to-cell. The increasing adoption of single-cell genomics analysis in cancer research is expected to drive the demand for advanced genomics products such as microfluidic instruments, dPCR, and single-cell sequencers, which will contribute to the growth of the US genomics market during the forecast period.

Major US Genomics Market Challenges

The shortage of skilled genetics professionals is a major challenge in the US genomics market. The performance of delicate and complicated procedures such as gene editing, multigene manipulation, sequence typing, and amplification is involved in genome studies. The use of genomics solutions in highly regulated applications such as drug development and disease diagnosis necessitates the maintenance of accuracy and precision, which increases their reliance on the skills and expertise of genetics professionals.

However, In the US, it has become a major problem to find these technically and professionally educated gene scientists because of their lack of availability. Markets and end-users are finding it challenging to source trained genetic professionals, geneticists, and genetic counselors who can ramp up their routine operations related to genomics-based screening and diagnosis, drug development, research, and counseling. The shortage of trained experts in the US genomics market has become one of the major challenges that will negatively impact the growth of the market in focus during the forecast period.

Buy Now Full Report and Discover More

Key US Genomics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

US Genomics Market Customer Landscape

Key US Genomics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Segment Overview

The US genomics market report forecasts market growth by revenue and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook (USD Million, 2017 - 2027)
    • Diagnostic
    • Drug discovery
    • Others
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospitals and clinics
    • Academic and research institutes
    • Pharmaceutical and biotechnology companies
    • Others
  • Solution Outlook (USD Million, 2017 - 2027)
    • Products
    • Services

US Genomics Market Scope

Report Coverage

Details

Page number

145

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 10.45%

Market growth 2023-2027

USD 5,284.67 million

Market structure

Fragmented

YoY growth 2022-2023(%)

9.85

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., QIAGEN NV, Thermo Fisher Scientific Inc., and Twist Bioscience Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this US Genomics Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the US Genomics Market between 2023 and 2027
  • Precise estimation of the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across the US
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of US genomics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Solution
    • Exhibit 07: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 08: Parent market
    • Exhibit 09: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 10: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 11: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
      • Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Genomics market in US 2017 - 2021
      • Exhibit 16: Historic Market Size – Data Table on genomics market in US 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 17: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 18: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Solution Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Solution Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 21: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 22: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 23: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 24: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 25: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 26: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 27: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 28: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 29: Chart on Comparison by Application
      • Exhibit 30: Data Table on Comparison by Application
    • 6.3 Diagnostic - Market size and forecast 2022-2027
      • Exhibit 31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
      • Exhibit 34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
    • 6.4 Drug discovery - Market size and forecast 2022-2027
      • Exhibit 35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
      • Exhibit 38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 39: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 41: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 42: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Application
      • Exhibit 43: Market opportunity by Application ($ million)
      • Exhibit 44: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 45: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 46: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 47: Chart on Comparison by End-user
      • Exhibit 48: Data Table on Comparison by End-user
    • 7.3 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 7.4 Academic and research institutes - Market size and forecast 2022-2027
      • Exhibit 53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
    • 7.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 61: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by End-user
      • Exhibit 65: Market opportunity by End-user ($ million)
      • Exhibit 66: Data Table on Market opportunity by End-user ($ million)

    8 Market Segmentation by Solution

    • 8.1 Market segments
      • Exhibit 67: Chart on Solution - Market share 2022-2027 (%)
      • Exhibit 68: Data Table on Solution - Market share 2022-2027 (%)
    • 8.2 Comparison by Solution
      • Exhibit 69: Chart on Comparison by Solution
      • Exhibit 70: Data Table on Comparison by Solution
    • 8.3 Products - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Products - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Products - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Products - Year-over-year growth 2022-2027 (%)
    • 8.4 Services - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Services - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Services - Year-over-year growth 2022-2027 (%)
    • 8.5 Market opportunity by Solution
      • Exhibit 79: Market opportunity by Solution ($ million)
      • Exhibit 80: Data Table on Market opportunity by Solution ($ million)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 82: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 83: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 84: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 85: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 86: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 87: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 88: Agilent Technologies Inc. - Overview
              • Exhibit 89: Agilent Technologies Inc. - Business segments
              • Exhibit 90: Agilent Technologies Inc. - Key offerings
              • Exhibit 91: Agilent Technologies Inc. - Segment focus
            • 12.4 BGI Genomics Co. Ltd.
              • Exhibit 92: BGI Genomics Co. Ltd. - Overview
              • Exhibit 93: BGI Genomics Co. Ltd. - Product / Service
              • Exhibit 94: BGI Genomics Co. Ltd. - Key offerings
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 95: Bio Rad Laboratories Inc. - Overview
              • Exhibit 96: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 97: Bio Rad Laboratories Inc. - Key news
              • Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 99: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 Color Health Inc.
              • Exhibit 100: Color Health Inc. - Overview
              • Exhibit 101: Color Health Inc. - Product / Service
              • Exhibit 102: Color Health Inc. - Key offerings
            • 12.7 Danaher Corp.
              • Exhibit 103: Danaher Corp. - Overview
              • Exhibit 104: Danaher Corp. - Business segments
              • Exhibit 105: Danaher Corp. - Key news
              • Exhibit 106: Danaher Corp. - Key offerings
              • Exhibit 107: Danaher Corp. - Segment focus
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 108: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 109: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 110: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 111: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 112: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Illumina Inc.
              • Exhibit 113: Illumina Inc. - Overview
              • Exhibit 114: Illumina Inc. - Business segments
              • Exhibit 115: Illumina Inc. - Key news
              • Exhibit 116: Illumina Inc. - Key offerings
              • Exhibit 117: Illumina Inc. - Segment focus
            • 12.10 LetsGetChecked
              • Exhibit 118: LetsGetChecked - Overview
              • Exhibit 119: LetsGetChecked - Product / Service
              • Exhibit 120: LetsGetChecked - Key offerings
            • 12.11 Myriad Genetics Inc.
              • Exhibit 121: Myriad Genetics Inc. - Overview
              • Exhibit 122: Myriad Genetics Inc. - Product / Service
              • Exhibit 123: Myriad Genetics Inc. - Key offerings
            • 12.12 Oxford Nanopore Technologies plc
              • Exhibit 124: Oxford Nanopore Technologies plc - Overview
              • Exhibit 125: Oxford Nanopore Technologies plc - Product / Service
              • Exhibit 126: Oxford Nanopore Technologies plc - Key offerings
            • 12.13 Pacific Biosciences of California Inc.
              • Exhibit 127: Pacific Biosciences of California Inc. - Overview
              • Exhibit 128: Pacific Biosciences of California Inc. - Product / Service
              • Exhibit 129: Pacific Biosciences of California Inc. - Key offerings
            • 12.14 PerkinElmer Inc.
              • Exhibit 130: PerkinElmer Inc. - Overview
              • Exhibit 131: PerkinElmer Inc. - Business segments
              • Exhibit 132: PerkinElmer Inc. - Key news
              • Exhibit 133: PerkinElmer Inc. - Key offerings
              • Exhibit 134: PerkinElmer Inc. - Segment focus
            • 12.15 QIAGEN NV
              • Exhibit 135: QIAGEN NV - Overview
              • Exhibit 136: QIAGEN NV - Product / Service
              • Exhibit 137: QIAGEN NV - Key news
              • Exhibit 138: QIAGEN NV - Key offerings
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 139: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 141: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Twist Bioscience Corp.
              • Exhibit 144: Twist Bioscience Corp. - Overview
              • Exhibit 145: Twist Bioscience Corp. - Product / Service
              • Exhibit 146: Twist Bioscience Corp. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 147: Inclusions checklist
                • Exhibit 148: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 149: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 150: Research methodology
                • Exhibit 151: Validation techniques employed for market sizing
                • Exhibit 152: Information sources
              • 13.5 List of abbreviations
                • Exhibit 153: List of abbreviations
              • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                genomics market

                QUICK BUY

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis